Abstract: Ultrasound devices are disclosed. The ultrasound devices have an elevational dimension. Different percentages of the aperture of the ultrasound device corresponding to different percentages of the elevational dimension are utilized in different applications. The resolution of imagine may be adjusted in connection with usage of different percentages of the aperture.

Abstract: Ultrasound devices are disclosed. The ultrasound devices have an elevational dimension. Different percentages of the aperture of the ultrasound device corresponding to different percentages of the elevational dimension are utilized in different applications. The resolution of imagine may be adjusted in connection with usage of different percentages of the aperture.

Abstract: Aspects of the technology described herein relate to control circuitry configured to turn on and off the ADC driver. In some embodiments, the control circuitry is configured to turn on and off the ADC driver in synchronization with sampling activity of an ADC, in particular based on when an ADC is sampling. The control circuitry may be configured to turn on the ADC driver during the hold phase of the ADC a time period before the track phase and to turn off the ADC driver during the hold phase a time period after the track phase. In some embodiments, the control circuitry is configured to control a duty cycle of the ADC driver turning on and off. In some embodiments, the control circuitry is configured to control a ratio between an off current and an on current in the ADC driver.

Abstract: Aspects of the technology described herein relate to an ultrasound device that may has a phase-locked loop (PLL) that includes a digitally-controlled oscillator (DCO). The DCO includes a plurality of current source unit cells with respective drain switches a plurality of current source unit cells with respective source switches. The plurality of current source unit cells with respective drain switches and the plurality of current source unit cells may have different circuit topologies. Switching on one of the plurality of current source unit cells with respective drain switches may cause a voltage transition at an internal node proceeding in one voltage direction and switching on one of the plurality of current source unit cells with respective source switches may cause a voltage transition at an internal node proceeding in the opposite voltage direction.

Abstract: Aspects of the technology described herein relate to an ultrasound device having a first analog-to-digital converter (ADC) configured to operate with a first ADC clock signal having a first timing delay and a second ADC configured to operate with a second ADC clock signal having a second timing delay. The first timing delay and the second timing delay may be different. The ultrasound device may further include delay control circuitry configured to control direct digital synthesis (DDS) circuitry to implement a first delay in ultrasound data from the first ADC and a second delay in ultrasound data from the second ADC. The first delay may correct for the first timing delay and the second delay may correct for the second timing delay.

Abstract: Aspects of the technology described herein relate to control circuitry configured to turn on and off the ADC driver. In some embodiments, the control circuitry is configured to turn on and off the ADC driver in synchronization with sampling activity of an ADC, in particular based on when an ADC is sampling. The control circuitry may be configured to turn on the ADC driver during the hold phase of the ADC a time period before the track phase and to turn off the ADC driver during the hold phase a time period after the track phase. In some embodiments, the control circuitry is configured to control a duty cycle of the ADC driver turning on and off. In some embodiments, the control circuitry is configured to control a ratio between an off current and an on current in the ADC driver.

Abstract: The present invention relates to a VEGF polypeptide that binds to A?. The present invention also relates to a compound that sequesters A?. And conversely, the invention relates to a compound that sequesters VEGF. Thus, the present invention also relates to a method of screening for a compound that inhibits the binding of VEGF to A?, and thus relates to prevention and treatment of Alzheimer's Disease.

Abstract: The present invention relates to a VEGF polypeptide that binds to A?. The present invention also relates to a compound that sequesters A?. And conversely, the invention relates to a compound that sequesters VEGF. Thus, the present invention also relates to a method of screening for a compound that inhibits the binding of VEGF to A?, and thus relates to prevention and treatment of Alzheimer's Disease.

Abstract: The present invention relates to a VEGF polypeptide that binds to &bgr;-amyloid. The present invention also relates to a compound that sequesters &bgr;-amyloid. And conversely, the invention relates to a compound that sequesters VEGF. Thus, the present invention also relates to a method of screening for a compound that inhibits the binding of VEGF to &bgr;-amyloid, and thus relates to diagnosis and treatment of Alzheimer's Disease.